Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Name
Yan Leyfman, MD
Title
Hematology Oncology - Meyer Cancer Center of New York-Presbyterian Hospital
Bio
The Future of Lymphoma Care: AI, Decision-Making and the Next Clinical Paradigm
09:20 - 10:10 PDT / 12:20 - 13:10 EDT / 17:20 - 18:10 BST
Dr. Yan Leyfman is a rising star in oncology and AI, recently recognized as a 40 Under 40 Emerging Leader in Cancer at the 2023 ASCO Annual Meeting. During the COVID-19 pandemic, he led the Immunology Division of the Global COVID-19 Taskforce, pioneering the first mechanisms for SARS-CoV-2 and COVI-Flu. His groundbreaking research on the cancer-COVID-19 interplay, presented at ASCO 2021 and published in BMC Journal of Hematology & Oncology, has significant clinical implications, earning him recognition as a 2022 International Hero in Healthcare by the Lymphoma, Leukemia & Myeloma Congress. Dr. Leyfman has made key contributions to advancing CAR T cell therapies, currently in clinical trials, earning honors such as the 2020 iCHEM Emerging International Scholar Award and the 2023 Young Scientists Phacilitate Advanced Therapies Award.
09:20 - 10:10 PDT / 12:20 - 13:10 EDT / 17:20 - 18:10 BST
Dr. Yan Leyfman is a rising star in oncology and AI, recently recognized as a 40 Under 40 Emerging Leader in Cancer at the 2023 ASCO Annual Meeting. During the COVID-19 pandemic, he led the Immunology Division of the Global COVID-19 Taskforce, pioneering the first mechanisms for SARS-CoV-2 and COVI-Flu. His groundbreaking research on the cancer-COVID-19 interplay, presented at ASCO 2021 and published in BMC Journal of Hematology & Oncology, has significant clinical implications, earning him recognition as a 2022 International Hero in Healthcare by the Lymphoma, Leukemia & Myeloma Congress. Dr. Leyfman has made key contributions to advancing CAR T cell therapies, currently in clinical trials, earning honors such as the 2020 iCHEM Emerging International Scholar Award and the 2023 Young Scientists Phacilitate Advanced Therapies Award.
